Ductal Carcinoma in Situ Clinical Trial
— MUST-BEOfficial title:
Effectiveness of Breast Cancer Screening in Women Aged 40-59: Digital Mammography With Supplemental Breast Ultrasonography Versus Digital Mammography Only
Verified date | October 2021 |
Source | Soonchunhyang University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Mammography screening has limited performance in young women or women with dense breasts although it is the only proven method for breast cancer screening that reduces the mortality. The investigators propose a multicenter trial of breast cancer screening to assess the effectiveness of supplemental ultrasonography for Korean women aged 40-59 years.
Status | Active, not recruiting |
Enrollment | 11880 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 40 Years to 59 Years |
Eligibility | Inclusion Criteria: - Women aged 40-59 years - No history of any cancer - No breast mammography (and ultrasonography, in case of intervention arm) after the introduction of digital mammography Exclusion Criteria: - Interstitial injection - Women with history of any cancer |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Soon Chun Hyang University Hospital | Bucheon | Gyeonggi-do |
Lead Sponsor | Collaborator |
---|---|
Soonchunhyang University Hospital | Ministry of Health & Welfare, Korea |
Korea, Republic of,
Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, Endo T, Fukao A, Tsuji I, Yamaguchi T, Ohashi Y, Fukuda M, Ishida T; J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet. 2016 Jan 23;387(10016):341-348. doi: 10.1016/S0140-6736(15)00774-6. Epub 2015 Nov 5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sensitivity of digital mammography with supplemental breast ultrasonography and digital mammography only | rate of positive results of the screening among histologically proved breast cancer patients | 1 year after the screening | |
Secondary | Cost-effectiveness of supplemental ultrasonography of the breast | Comparison of the cost for detecting one breast cancer patient by two groups. | 1 year after the screening | |
Secondary | Cost-utility of supplemental ultrasonography of the breast | Measurement of the incremental cost-utility ratio, which is calculated by dividing the difference in costs by difference in the quality-adjusted life year (QALY). | 1 year after the screening |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02889458 -
Hong Kong Breast Cancer Study
|
||
Completed |
NCT00757302 -
Intraoperative Gamma Camera for Breast Cancer Surgery
|
Phase 3 | |
Active, not recruiting |
NCT03216421 -
Intraoperative Radiation Therapy (IORT) in DCIS
|
N/A | |
Completed |
NCT03775213 -
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
|
N/A | |
Active, not recruiting |
NCT00605982 -
Breast MRI as a Preoperative Tool for DCIS
|
N/A | |
Enrolling by invitation |
NCT04365114 -
Patient Outcomes From Second Film-readers and Test Threshold Relaxation in Breast Screening
|
||
Completed |
NCT04248179 -
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.
|
Phase 4 | |
Withdrawn |
NCT05032079 -
Subzero and Scorpion Trial
|
N/A | |
Recruiting |
NCT05218044 -
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
|
N/A | |
Active, not recruiting |
NCT01644669 -
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
|
N/A | |
Recruiting |
NCT06133647 -
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
|
||
Completed |
NCT01815476 -
The Prone Breast Radiation Therapy Trial
|
N/A | |
Not yet recruiting |
NCT06033092 -
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
|
Phase 2 | |
Terminated |
NCT02137252 -
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
|
Phase 2 | |
Terminated |
NCT01060345 -
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
|
Phase 2 | |
Recruiting |
NCT00669747 -
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
|
Phase 2 | |
Completed |
NCT00742222 -
Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
|
Phase 4 | |
Recruiting |
NCT02928978 -
Ruxolitinib for Premalignant Breast Disease
|
Phase 2 | |
Completed |
NCT03375892 -
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
|
N/A | |
Withdrawn |
NCT03437915 -
BrUOG 351: PRE-OPERATIVE APBI USING NIBB
|
N/A |